Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment.
Latagliata R, Breccia M, Carmosino I, Sarlo C, Montefusco E, Mancini M, Natalino F, Chistolini A, De Cuia R, Russo E, Morano GS, Biondo F, Spadea A, Mandelli F, Alimena G.
Latagliata R, et al. Among authors: carmosino i.
Leuk Res. 2005 Mar;29(3):287-91. doi: 10.1016/j.leukres.2004.08.002.
Leuk Res. 2005.
PMID: 15661264
Clinical Trial.